Statement Of Cash Flows [Abstract]

Medistim - Filing #2546064

Concept As at
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
113 189 NOK
113 491 NOK
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities
16 399 NOK
9 251 NOK
Cash flows from (used in) investing activities
29 726 NOK
21 102 NOK
Cash flows from (used in) financing activities [abstract]
Payments of lease liabilities, classified as financing activities
8 712 NOK
7 312 NOK
Dividends paid, classified as financing activities
82 180 NOK
68 396 NOK
Other inflows (outflows) of cash, classified as financing activities
6 009 NOK
5 404 NOK
Cash flows from (used in) financing activities
84 883 NOK
70 304 NOK
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
2 651 NOK
1 066 NOK
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes
1 231 NOK
23 151 NOK
Cash and cash equivalents
146 082 NOK
144 164 NOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.